Critically analyze the implications of amending the Civil Liability for Nuclear Damage Act, 2010 for private sector participation in India's nuclear power sector.

India's installed nuclear capacity is roughly 8.8 GW against the Nuclear Energy Mission's target of 100 GW by 2047 [3]. The supplier-recourse regime of the Civil Liability for Nuclear Damage Act, 2010 — now replaced by the SHANTI Act, 2025 [1] — was long identified as the decisive legal barrier to private capital.

What the liability reform changes

• The SHANTI Act, 2025 replaces both the Atomic Energy Act, 1962 and the CLND Act, 2010, and permits licensing of Indian companies and government–private joint ventures to build and operate plants under a statutory regulatory framework [1].
• Operator liability moves to a tiered cap, ranging from ₹100 crore to ₹3,000 crore by plant capacity [1].
• Automatic supplier liability is withdrawn; the operator's right of recourse now survives only through an express written contract or where damage is caused intentionally [2].

Enabling implications

• Bankability: capped, quantifiable exposure lets lenders and insurers price nuclear risk, unlocking the ₹20,000 crore Small Modular Reactor programme and five indigenous SMRs targeted by 2033 [4].
• Technology access: removing open-ended supplier risk revives stalled foreign vendor negotiations and deepens the domestic equipment supply chain [2].
• Climate and energy security: private baseload capacity supports the near-tripling of capacity to over 22 GW by 2031-32 and the Net Zero 2070 pathway [3].

Critical concerns

• A ₹3,000 crore ceiling is modest against catastrophic damage; residual cost shifts to the exchequer and victims — the Bhopal experience counsels caution.
• Diluting supplier liability weakens the safety-by-design incentive for equipment manufacturers.
• Regulatory bandwidth must scale to supervise multiple private operators, not one state entity.
• A thin nuclear insurance market, land acquisition and local acceptance remain unaddressed by liability reform alone.
• Foreign-incorporated companies still cannot hold licences, capping FDI depth [1].

The reform correctly diagnoses liability as the binding constraint, but investor certainty must be matched by victim certainty. Periodic indexation of the liability cap, a deepened insurance pool and a well-resourced, independent regulator would let private participation advance without diluting the constitutional guarantee of life under Article 21.